Henry Wong

9PUBLICATIONS
29CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsBiologically active moleculesAutonomic nervous systemCharacterisation of biological macromoleculesToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 11, 2026
Development of a Second-Generation RARα Selective Antagonist as an Orally Bioavailable, Effective, Safe, and Reversible Male Contraceptive.

|Mar 03, 2026
Correction to "From Discovery to Clinical Trial: YCT-529, an Oral NonHormonal Male Contraceptive Targeting the Retinoic Acid Receptor Alpha".

Rui Shi, Md Abdullah Al Noman, Nadja Mannowetz

|Jan 12, 2026
From Discovery to Clinical Trial: YCT-529, an Oral NonHormonal Male Contraceptive Targeting the Retinoic Acid Receptor Alpha.

Rui Shi, Md Abdullah Al Noman, Nadja Mannowetz

|Jun 26, 2025
Strategies to Develop Na,K-ATPase-α4 Inhibitors as Male Contraceptives.

Shameem S Syeda, Gladis Sánchez, Jeffrey P McDermott

|Jun 22, 2024
Discovery of a CK2α'-Biased ATP-Competitive Inhibitor from a High-Throughput Screen of an Allosteric-Inhibitor-Like Compound Library.

Deepti Mudaliar, Rachel H Mansky, Angel White

|Feb 08, 2024
Identification of CK2α' selective inhibitors by the screening of an allosteric-kinase-inhibitor-like compound library.

Deepti Mudaliar, Rachel H Mansky, Angel White

Pageof 2

Frequent Collaborators

6 joint publications

Gunda I Georg

5 joint publications

Jon Hawkinson

2 joint publications

Michael A Walters

2 joint publications

Rocio Gomez-Pastor